Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-07-02

Clinical Trial Update: A Randomized Study Evaluating the Efficacy and Safety of Timolol Ophthalmic Solution as an Acute Treatment of Migraine [Phase 2]

View source ↗

Summary

Phase 2 randomized trial assessing timolol ophthalmic solution for acute treatment of migraine; study completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Timolol ophthalmic solution (timolol)

Snippet

Sponsor: University of Kansas Medical Center | Conditions: Migraine | Phase 2 | Status: COMPLETED | Results posted: 2019-07-02